Latest News

Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease.

Huntington Disease Center at Georgetown Designated As Center of Excellence
The Huntington’s Disease Society of America (HDSA) has designated the Huntington Disease Care, Education and Research Center at Georgetown as an HDSA Center of Excellence for 2016.

Georgetown Hosts Research Summit on Concussions in Females
Georgetown Hosts Research Summit on Concussions in Females
Georgetown University Medical Center will host the first summit to explore gender differences of female brain injuries

Moussa and Pagan
Cancer Drug Improved Cognition and Motor Skills in Small Parkinson’s Clinical Trial
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small phase I clinical trial, report researchers at Georgetown University Medical Center (GUMC) in Washington.